Harbin Gloria Pharmaceuticals Co., Ltd

Share · CNE100000QG8 (XSHE)

Overview

No Price

Closing Price XSHE 04.11.2025: 3,40 CNY

04.11.2025 07:04

Current Prices from Harbin Gloria Pharmaceuticals Co., Ltd

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
SHENZHEN STOCK EXCHANGE	002437.SZ	CNY	04.11.2025 07:04	3,40 CNY	-0,06 CNY -1,73 %

Share Float & Liquidity

Free Float 72,09 %

Shares Float 1,58 B

Shares Outstanding 2,2 B

Company Profile for Harbin Gloria Pharmaceuticals Co., Ltd Share

Harbin Gloria Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products primarily in the People's Republic of China. It offers cardiac cerebrovascular medication, skeletal muscle system, vitamins and minerals, urinary system medication, antitumor medication, endocrine medicine, anti-infective drugs, respiratory medication, antihistamine, peptic, and other products. Harbin Gloria Pharmaceuticals Co., Ltd. was founded in 2000 and is based in Harbin, the People's Republic of China.

Get up to date insights from finAgent about Harbin Gloria Pharmaceuticals Co., Ltd

Company Data

Name Harbin Gloria Pharmaceuticals Co., Ltd

Company Harbin Gloria Pharmaceuticals Co., Ltd

Website https://www.gloria.cc

Primary Exchange

SHENZHEN STOCK EXCHANGE

ISIN CNE100000QG8

Asset Class Share

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

CEO Leifeng Guo

Market Capitalization 7 Mrd.

Country China

Currency CNY

Employees 3,1 T

Address No. 29, Beijing Road, 150025 Harbin

IPO Date 2011-10-27

Ticker Symbols

Name	Symbol
SHENZHEN STOCK EXCHANGE	002437.SZ

More Shares

Investors who hold Harbin Gloria Pharmaceuticals Co., Ltd also have the following shares in their portfolio:

Creo Co.,Ltd. Share

PROSHARES ULTRA CONSUMER SERVICES ETF

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog